Hosted on MSN
MicroPort NeuroTech steps up competition in brain vascular devices with new embolic agent trial
MicroPort NeuroTech Limited (HK:2172) announced an update on their ongoing clinical study. Study Overview The clinical study “a Prospective, Multi-center, Open-label, Non-inferiority, Randomized, ...
(MENAFN- EIN Presswire) EINPresswire/ -- The Micro-Electro-Mechanical Systems (MEMS) Oscillators market is dominated by a mix of global leading semiconductor manufacturers and specialized MEMS ...
Summary is AI generated, newsroom reviewed. Ohio’s $120 billion pension fund OPERS bought $43 million in MicroStrategy stock. The purchase gives indirect exposure to Bitcoin without holding it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback